Metraipolis › archive › dc_0dd452e8fc7e

ADH-1 — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/ADH-1
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-06T23:44:22.303Z
SHA-256 of the archived text
48108a6921f414de1936088930388ff774091d228cf5d4a05e9fd28d084eb2d2
Stable URL of this page
https://metraipolis.com/documento/dc_0dd452e8fc7e

How to cite

ADH-1 — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/ADH-1 (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_0dd452e8fc7e (Metraipolis archive dc_0dd452e8fc7e, sha256 48108a6921f414de1936088930388ff774091d228cf5d4a05e9fd28d084eb2d2)
BibTeX
@misc{dc0dd452e8fc7e,
  title = {ADH-1 — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/ADH-1},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_0dd452e8fc7e; sha256 48108a6921f414de1936088930388ff774091d228cf5d4a05e9fd28d084eb2d2},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/ADH-1. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

ADH-1 (proposed brand name Exherin) is a cyclic peptide antineoplastic drug developed by Adherex Technologies. ADH-1 selectively and competitively binds to and blocks N-cadherin, which may result in disruption of tumor vasculature, inhibition of tumor cell growth, and the induction of tumor cell and endothelial cell apoptosis. N-cadherin, a cell- surface transmembrane glycoprotein of the cadherin superfamily of proteins involved in calcium-mediated cell–cell adhesion and signaling mechanisms; may be upregulated in some aggressive tumors and the endothelial cells and pericytes of some tumor blood vessels. In 2006, Adherex and NCI formed a clinical trial agreement stating that NCI will sponsor clinical trials of ADH-1 in a variety of cancer types. ADH-1 received orphan drug status from the FDA in 2008. In a pilot study (phase I trial), ADH-1 intravenous pretreatment before chemotherapy in metastatic melanoma completely destroyed tumors in half of patients. It is being investigated in phase II trials for advanced extremity melanoma.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «ADH-1» — https://en.wikipedia.org/wiki/ADH-1
Wikidata Q4651113: «composto chimico» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q4651113
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/ADH-1?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1344338912, consultata il 2026-11-06T23:40:52.704Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: aa7b00268d1b76c9e2377f8395050bdb3f37a2c3ad615055fbab47b7f61d3023